Stockscreener 앱 받기
1.11
4.72%
0.05
시간 외 거래:
1.10
-0.01
-0.90%
Creative Medical Technology Holdings Inc 주식(CELZ)의 최신 뉴스
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism? - Stocktwits
Creative Medical Technology Increases Authorized Shares to 100 Million - Minichart
Creative Medical Expands Authorized Shares and Warrant Exercise - TipRanks
Creative Medical Technology Holdings Inc. (CELZ) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Creative Medical Technology Holdings Inc. (CELZ) Peer Comparison – Compare with Others - Value Research
Creative Medical Technology Holdings Inc. (CELZ) Key Financial Ratios – Valuation, Profitability & More - Value Research
CELZ Looks 171.4% Overvalued on GF Value™ - GuruFocus
CELZ Looks 142.9% Overvalued on GF Value™ - GuruFocus
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning - The Manila Times
Creative Medical completes enrollment in chronic back pain trial - Investing.com
Creative Medical Technology Holdings Completes Enrollment And Treatment In FDA-Cleared ADAPT Clinical Trial Evaluating CELZ-201 / Olastrocel - marketscreener.com
Creative Medical finishes treating back-pain patients who use opioids - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Creative (CELZ) EPS and Revenue Review: The EPS Result Is Below Expectation on the Day; Market Follow-Through: The Share Price Sheds 1.82% on the DayGuidance Accuracy Score - vinanet.vn
CELZ Q2 2026 Earnings: EPS Miss of -$0.41 Reflects Pre-Revenue Pipeline InvestmentCFO Commentary Report - vinanet.vn
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket - Sahm
CELZ Q2 2026 Earnings: EPS Misses by 3.07% as Pre-Revenue Losses Persist; Stock Climbs 8.75%Cash Flow Report - vinanet.vn
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CELZ Jumps As New Diabetes Patent Fuels Volatile Rally - StocksToTrade
Creative Medical Technology | DEF 14A: Definitive information statements - Moomoo
Creative Medical net loss widens 22.5% to $1.51 million in Q2 2026 - Bitget
Creative Medical Technology Holdings, Inc. (CELZ) stock price, news, quote and history - Yahoo Finance Singapore
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. 2026: Revenue $0 Net income ($1.51M), EPS ($0.41) — 10-Q Summary - TradingView
Creative Medical Technology (NASDAQ: CELZ) Q2 loss, cash rises to $8.7M - Stock Titan
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Top Microcaps CELZ, PRSO, HCWC, TOON: Shorted Stocks to Watch in August 2026 - FinancialContent
Which stocks have an unusual volume on Friday? - ChartMill
Creative Medical Technology Holdings Inc (CELZ) Stock News Today - TradingKey
$Creative Medical Technology (CELZ.US)$ 小赚 - Moomoo
$Creative Medical Technology (CELZ.US)$ sky is so clear and the sun is out 🌄 - Moomoo
CELZ Stock Jumps As New Diabetes Patent Fuels Momentum - stockstotrade.com
$Creative Medical Technology (CELZ.US)$ 🫣 - Moomoo
$Creative Medical Technology (CELZ.US)$ double dipped😋 - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Creative Medical Technology Stock Surges After Key Patent Win - Benzinga
Thursday's session: most active stocks - ChartMill
Medical Stocks To ConsiderAugust 6th - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Creative Medical receives patent allowance for diabetes exosome tech By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Shares Surge as Traders Appear to Latch Onto Earlier Pipeline Updates and a Tiny-float Setup - Moomoo
Creative Medical receives patent allowance for diabetes exosome tech - Investing.com
Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy - Yahoo Finance
Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - marketscreener.com
Exosome application gets U.S. allowance to target Type 1 diabetes autoimmunity - Stock Titan
CELZ Stock Slides As Traders Track High-Volatility Setup - StocksToTrade
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
CELZ Stock Whipsaws As Traders Focus On Cash And Charts - StocksToTrade
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket - Benzinga
$Creative Medical Technology (CELZ.US)$ the timeframe i stare at all day. then higher timeframes for trend and major resistance and support areas. combine them. and you golden. - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing (Aug 3, 2026) - Stock Titan
Creative Medical Technology Holdings Inc (CELZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Creative Medical Technology Holdings (CELZ) Edges Lower Near Key Support LevelValue Factor - vinanet.vn
Creative Medical Technology Holdings Inc (CELZ) Cash Flow - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Institutional Confidence - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Creative Medical Technology Holdings Inc - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Form S-3 Creative Medical Technology Holdings Inc For: 24 July - Investing.com Nigeria
Creative Medical Technology (CELZ) Holds at $0.81 as Consolidation Narrows Trading RangeLeading Diagonal - vinanet.vn
0.86%
0.31%
자본화:
|
볼륨(24시간):